III Capital Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

III Capital Management’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,579	Closed	-$45	–	119
2024 Q2	$45	Sell	36,579 -5,216	-12%	-$180	﹤0.01%	119
2024 Q1	$5.75K	Hold	41,795	–	–	﹤0.01%	114
2023 Q4	$4.43K	Hold	41,795	–	–	﹤0.01%	143
2023 Q3	$4.51K	Hold	41,795	–	–	﹤0.01%	149
2023 Q2	$7.25K	Hold	41,795	–	–	﹤0.01%	131
2023 Q1	$4.15K	Hold	41,795	–	–	﹤0.01%	120
2022 Q4	$4K	Hold	41,795	–	–	﹤0.01%	124
2022 Q3	$7K	Hold	41,795	–	–	﹤0.01%	141
2022 Q2	$9K	Hold	41,795	–	–	﹤0.01%	166
2022 Q1	$16K	Buy	41,795 +15,895	+61%	+$8.08K	﹤0.01%	143
2021 Q4	$23K	Buy	25,900 +9,396	+57%	+$11.8K	﹤0.01%	150
2021 Q3	$26K	Buy	+16,504	New	+$20K	﹤0.01%	167

III Capital Management's EFTRW Position: Q3 2024 in Review

III Capital Management sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 36,579 shares — an estimated $45 sold.

III Capital Management first reported a position in EFTRW in Q3 2021 and held it in 12 quarters. The position peaked at $26K in Q3 2021. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

III Capital Management reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
III Capital Management sold 36,579 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $45.
III Capital Management first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q3 2021 and held it in 12 quarters.
III Capital Management's eFFECTOR Therapeutics, Inc. Warrant position peaked at $26K in Q3 2021.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on III Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.